- WORLD VIEW
How my institution strengthened research despite chronic underfunding
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 648, 500 (2025)
doi: https://doi.org/10.1038/d41586-025-04050-z
Competing Interests
A.S.’s work is funded in part by the US National Institutes of Health, the US Department of Energy, the US National Science Foundation, the American Cancer Society, the Chan Zuckerberg Initiative Foundation, Novartis, Regeneron, AstraZeneca, Novo Nordisk and Roche. A.S. serves in unpaid advisory or leadership roles at the Royal Society of Medicine (UK), the International Union Against Cancer, the Society for Immunotherapy of Cancer, the US National Academies of Sciences, the Engineering and Medicine Board on Health Sciences Policy, the Association of American Medical Colleges Leadership Group on Research Advancement and Development, the Diaspora Human Genomics Institute and the Meharry–Vanderbilt Alliance.
The financial shackling of historically Black universities in the United States
End racism in science
A Black mathematical history
Most US professors are trained at same few elite universities
